Snezana is a myeloma patient the president of the Serbian Association of Myeloma Patients (Udruženje obolelih od multiplog mijeloma Srbije). She spent years working as a business consultant covering finance, regulatory frameworks, international trade and distribution and also served as finance director with extensive experience at board level. Snezana’s mission is sharing knowledge, experiences, advocacy strategies, and developing collaboration between different EU regions to improve the capacities of CEE country myeloma associations.
New ways to administer daratumumab and isatuximab get positive recommendations from EMA
At the end of March, the Committee for Medicinal Products for Human Use (CHMP) announced two positive recommendations for new ways of administering the existing myeloma drugs daratumumab and isatuximab.…